Related Experiment Video
Updated: Apr 28, 2026
11:39
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
38.4K
Multimodal therapy of idiopathic pyoderma gangrenosum
Victoria Sharon, Barbara Burrall, Forum Patel
1University of California, Davis.
Dermatology Online Journal
|June 20, 2014
Summary
Severe pyoderma gangrenosum (PG) in a young patient required combination therapy. This case highlights the effectiveness of adalimumab alongside prednisone and cyclosporine, plus wound care, for refractory PG.
Area of Science:
- Dermatology
- Immunology
Background:
- Pyoderma gangrenosum (PG) is a rare, ulcerative neutrophilic dermatosis.
- It often presents with lower extremity lesions refractory to standard treatments.
Observation:
- A 13-year-old girl presented with rapidly progressing cutaneous bullae and ulcerations.
- Biopsy confirmed neutrophilic dermatosis, with negative infectious and autoimmune work-up.
Findings:
- The patient's condition, diagnosed as pyoderma gangrenosum, initially responded poorly to prednisone and cyclosporine monotherapy.
- Combination therapy with adalimumab, prednisone, and cyclosporine achieved remission.
- Aggressive wound care, including compression and debridement, was crucial for ulcer healing.
Implications:
- Severe pyoderma gangrenosum often necessitates combination immunosuppressive therapy.
- Adalimumab can be effective in refractory cases of PG.
- Comprehensive wound care is essential for successful management and healing of pyoderma gangrenosum ulcers.
Related Concept Videos
01:27Peripheral Artery Disease III: Interprofessional Care
653
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
653
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
745
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
745
01:29Chronic Pancreatitis II: Collaborative Care
561
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
561
01:29Drugs for Treatment of Ulcerative Colitis in IBD
700
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
700
01:23Gastritis III: Clinical Manifestations and Management
1.9K
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.9K
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
2.5K
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
2.5K